Food and Drug Administration

  1. How NDAs Work and Why They're Important

    A non-disclosure agreement, or NDA, is a legal document that keeps the lid on sensitive ...
  2. Could Amgen's Next Drug Be Worth $100 Billion?

    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol ...
  3. 3 Things That Could Hold Intuitive Surgical Back

    Taking a long-term view that favors Intuitive Surgical developer increasing in value, ...
  4. Did Orexigen Make A Big Mistake?

    Developing drugs isn't cheap. Drugmakers spend $1.4 billion in direct costs to bring ...
  5. Are These Biogen Idec's Next Blockbusters?

    Biogen Idec is already a company worth watching, but it’s recently launched hemophilia ...
  6. Why Does Wall Street Hate MannKind?

    Since peaking, MannKind's shares have tumbled 25% due in large part to Wall Street's ...
  1. Could Amgen's Next Drug Be Worth $100 Billion?

    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol ...
  2. 3 Things That Could Hold Intuitive Surgical Back

    Taking a long-term view that favors Intuitive Surgical developer increasing in value, ...
  3. Did Orexigen Make A Big Mistake?

    Developing drugs isn't cheap. Drugmakers spend $1.4 billion in direct costs to bring ...
  4. Are These Biogen Idec's Next Blockbusters?

    Biogen Idec is already a company worth watching, but it’s recently launched hemophilia ...
  5. Why Does Wall Street Hate MannKind?

    Since peaking, MannKind's shares have tumbled 25% due in large part to Wall Street's ...
  6. What’s The Drug That Will Finally Fight Obesity?

    Orexigen just pulled back the curtain on interim results for a cardiac study that ...
Trading Center